Enrolling By Invitation

PHACE - Prospective Genetic Investigation

NCT05133245•Vanderbilt University Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

PHACE Syndrome

Interventions

Diagnostic study only

Locations

1

United States

Locations (1)

Vanderbilt Eye Institute

Nashville, Tennessee, United States

Key Dates

Start Date

November 1, 2021

Primary Completion Date

November 1, 2026

Completion Date

November 1, 2026

Last Updated

December 23, 2025

Sponsors

Lead Sponsor

Vanderbilt University Medical Center

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 23, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions